Sophia Gayle

Sophia Gayle

Company: Cybrexa

Job title: Biology Director


Expanding Selection of Tubulin & TOPI Inhibitor Payloads for Improved Tumor Specific Delivery by Peptide Drug Conjugate 1:15 pm

Considering the stability of linker-warhead peptide conjugates when working with TOPI inhibitor and tubulin inhibitors Improving tumor specificity of warhead delivery for improved therapeutic window Describing preclinical efficacy and safety profile, both clinical and non-clinical for Auristatin and Topo1 assetsRead more

day: Conference Day Two

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.